Immune crosstalk in cancer progression and metastatic spread: a complex conversation
- PMID: 32024984
- DOI: 10.1038/s41577-019-0271-z
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Abstract
Metastatic disease is responsible for approximately 90% of cancer deaths. For successful dissemination and metastasis, cancer cells must evade detection and destruction by the immune system. This process is enabled by factors secreted by the primary tumour that shape both the intratumoural microenvironment and the systemic immune landscape. Here, we review the evidence of aberrant immune cell crosstalk in metastasis formation and the role that primary tumours play in hijacking these interactions in order to enhance their metastatic potential. Moreover, we highlight the intriguing parallels between the inflammatory pathways underlying inflammatory disorders and cancer progression.
References
-
- Ehrlich, P. Über den jetzigen stand der karzinomforschung. Nederlandsch Tijdschr. voor Geneeskunde 5, 273–290 (1909).
-
- Coley, W. B. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. 1. Am. J. Med. Sci. 105, 487–511 (1893). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical